| Revenue | DKK 0 | — |
| EBITDA | DKK 0 | — |
| Net profit | DKK 0 | +100% |
| Total assets | DKK 52K | +0% |
| Equity | DKK -6K | +0% |
| Employees | — | — |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | -4 | -43 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | -4 | -43 | 0 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 0 | 0 | 0 | 0 | 0 | -4 | -43 | 0 |
| Net financials | -300 | 300 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -300 | 300 | 0 | 0 | 0 | -4 | -43 | 0 |
| Tax | -0 | -0 | -0 | -0 | -0 | -1 | -0 | -0 |
| Net profit | -300 | 300 | 0 | 0 | 0 | -3 | -43 | 0 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 51 | 51 | 51 | 51 | 90 | 91 | 52 | 52 |
| Equity | -299 | 1 | 1 | 1 | 40 | 37 | -6 | -6 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 350 | 50 | 50 | 50 | 50 | 54 | 58 | 58 |
| Total debt | 350 | 50 | 50 | 50 | 50 | 54 | 58 | 58 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BC Management | Management | 2022 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Entelechy IVS | Company | 15.0% | 5.0% | 2016 |
Figlia IVS | Company | 15.0% | 5.0% | 2016 |
AG Copenhagen Holding IVS | Company | 15.0% | 5.0% | 2016 |
Nedug Holding IVS | Company | 15.0% | 5.0% | 2016 |
Invictus Invest ApS | Company | 100.0% | 100.0% | 2022 |
| Individual | 15.0% | 5.0% | 2021 | |
| Individual | 15.0% | 5.0% | 2021 | |
| Individual | 15.0% | 5.0% | 2021 | |
| Individual | 15.0% | 5.0% | 2021 |
| Person | Role here | Other companies |
|---|---|---|
| Bolette Christophersen | Management | 0 companies |